AbCellera to Announce Top-Line Results from the Phase 2 Trial of ABCL635 for the Treatment of Moderate-to-Severe VMS Due to Menopause on Monday, August 10, 2026

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 8/11/2026

1. RKLB
2. SION
3. SPY
4. NVDA
5. MNDY
6. INTC
7. CSQR
8. ACH
9. B
10. RHP

Go back to AbCellera to Announce Top-Line Results from the Phase 2 Trial of ABCL635 for the Treatment of Moderate-to-Severe VMS Due to Menopause on Monday, August 10, 2026
(NASDAQ: ABCL) Delayed: 9.34 +2.41 (34.78%)
Previous Close $6.93    52 Week High $ 
Open $8.76    52 Week Low $ 
Day High $10.01    P/E N/A 
Day Low $8.40    EPS $ 
Volume 46,022,181